Nanjing Vishee Medical Technology Co Ltd (688580) - Total Liabilities
Based on the latest financial reports, Nanjing Vishee Medical Technology Co Ltd (688580) has total liabilities worth CN¥107.49 Million CNY (≈ $15.73 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Nanjing Vishee Medical Technology Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Nanjing Vishee Medical Technology Co Ltd - Total Liabilities Trend (2013–2025)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688580 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Nanjing Vishee Medical Technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Nanjing Vishee Medical Technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangxi Sanchuan Water Meter
SHE:300066
|
China | CN¥505.08 Million |
|
Guangxi Wuzhou Communications Co Ltd
SHG:600368
|
China | CN¥4.63 Billion |
|
United Overseas Australia Ltd
AU:UOS
|
Australia | AU$505.00 Million |
|
Shenzhen Sunxing Light Alloys
SHG:603978
|
China | CN¥2.95 Billion |
|
Lian Hwa Foods Corp
TW:1231
|
Taiwan | NT$7.70 Billion |
|
Metro Healthcare Indonesia
JK:CARE
|
Indonesia | Rp1.17 Trillion |
|
Cangzhou Dahua Co Ltd
SHG:600230
|
China | CN¥1.68 Billion |
|
Metalurgica Gerdau S.A
SA:GOAU3
|
Brazil | R$28.08 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down Nanjing Vishee Medical Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688580 stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.65 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nanjing Vishee Medical Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nanjing Vishee Medical Technology Co Ltd (2013–2025)
The table below shows the annual total liabilities of Nanjing Vishee Medical Technology Co Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥216.00 Million ≈ $31.61 Million |
+11.98% |
| 2024-12-31 | CN¥192.90 Million ≈ $28.23 Million |
+7.60% |
| 2023-12-31 | CN¥179.27 Million ≈ $26.23 Million |
+15.16% |
| 2022-12-31 | CN¥155.67 Million ≈ $22.78 Million |
+47.30% |
| 2021-12-31 | CN¥105.68 Million ≈ $15.46 Million |
-18.36% |
| 2020-12-31 | CN¥129.45 Million ≈ $18.94 Million |
-13.32% |
| 2019-12-31 | CN¥149.35 Million ≈ $21.86 Million |
+33.11% |
| 2018-12-31 | CN¥112.20 Million ≈ $16.42 Million |
+20.46% |
| 2017-12-31 | CN¥93.15 Million ≈ $13.63 Million |
+80.83% |
| 2016-12-31 | CN¥51.51 Million ≈ $7.54 Million |
+151.36% |
| 2015-12-31 | CN¥20.49 Million ≈ $3.00 Million |
+4.03% |
| 2014-12-31 | CN¥19.70 Million ≈ $2.88 Million |
-39.74% |
| 2013-12-31 | CN¥32.69 Million ≈ $4.78 Million |
-- |
About Nanjing Vishee Medical Technology Co Ltd
Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) for use in anxiety disorders, movement disorders, and ADHD applications; MagNeuro ONE, a TMS therapy system with navigation for use in anxiety disorders applications; and MagBelle, a pelvic floor m… Read more